For couples at a high risk for genetic disease, the decision to have children is not a simple one. Couples must weigh their desire for children with the likelihood of a chromosomal defect. Thankfully, preimplantation genetic diagnosis, commonly referred to as PGD, allows genetic diseases to be identified in embryos as a part of in vitro fertilization. The embryos are tested prior to transfer and implantation to ensure healthy embryos are transferred.
PGD is a testing method that allows for the diagnosis of genetic disease in embryos. PGD is performed by removing cells from the developing embryo. The process of removing the cells does not harm the embryo and has no lasting effects. Those cells can then be analyzed to determine if genetic disease is present. The goal is to select the healthiest embryos – which are most likely to result in a live birth – for transfer and implantation.
Although PGD testing evaluates the embryo’s cells, it is not a replacement for testing during pregnancy. Couples who have PGD done should still follow their doctor’s recommendation for prenatal care and treatment.
Some insurance policies provide coverage for PGD. To determine what testing is covered by your insurance company, review your plan documents or speak with an insurance representative. Additionally, the finance team at your fertility center can provide detailed information on your coverage and potential out of pocket costs.
PGD should be considered for couples that answer yes to any of the following:
Find out more about genetic testing and IVF by contacting the experts at New Hope Fertility Center today. Please click the link below to enter your information and New Hope will contact you, or simply call 212-517-7676. Thank You.